825
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Effects of a microbial pigment violacein on the activities of protein kinases

, , & | (Reviewing Editor)
Article: 1259863 | Received 09 Sep 2016, Accepted 04 Nov 2016, Published online: 28 Nov 2016

References

  • Alshatwi, A. A., Subash-Babu, P., & Antonisamy, P. (2016). Violacein induces apoptosis in human breast cancer cells through up regulation of BAX, p53 and down regulation of MDM2. Experimental and Toxicologic Pathology, 68, 89–97.10.1016/j.etp.2015.10.002
  • Balibar, C. J., & Walsh, C. T. (2006). In vitro biosynthesis of violacein from l -tryptophan by the enzymes VioA−E from Chromobacterium violaceum. Biochemistry, 45, 15444–15457.10.1021/bi061998z
  • Bromberg, N., Dreyfuss, J. L., Regatieri, C. V., Palladino, M. V., Durán, N., Nader, H. B., … Justo, G. Z. (2010). Growth inhibition and pro-apoptotic activity of violacein in Ehrlich ascites tumor. Chemico-Biological Interactions, 186, 43–52.10.1016/j.cbi.2010.04.016
  • Bromberg, N., Justo, G. Z., Haun, M., Durán, N., & Ferreira, C. V. (2005). Violacein cytotoxicity on human blood lymphocytes and effect on phosphatases. Journal of Enzyme Inhibition and Medicinal Chemistry, 20, 449–454.10.1080/14756360500273052
  • Choi, S. Y., Yoon, K., Lee, J. I., & Mitchell, R. J. (2015). Violacein: properties and production of a versatile bacterial pigment. BioMed Research International, 2015, 465056. doi:10.1155/2015/465056
  • Durán, N., & Menck, C. F. M. (2001). Chromobacterium violaceum: A review of pharmacological and industrial perspectives. Critical Reviews in Microbiology, 27, 201–222.10.1080/20014091096747
  • Durán, M., Ponezi, A. N., Faljoni-Alario, A., Teixeira, M. F. S., Justo, G. Z., & Durán, N. (2012). Potential applications of violacein: a microbial pigment. Medicinal Chemistry Research, 21, 1524–1532.10.1007/s00044-011-9654-9
  • Ferreira, C. V., Bos, C. L., Versteeg, H. H., Justo, G. Z., Durán, N., & Peppelenbosch, M. P. (2004). Molecular mechanism of violacein-mediated human leukemia cell death. Blood, 104, 1459–1464.10.1182/blood-2004-02-0594
  • Hoshino, T. (2011). Violacein and related tryptophan metabolites produced by Chromobacterium violaceum: biosynthetic mechanism and pathway for construction of violacein core. Applied Microbiology and Biotechnology, 91, 1463–1475.10.1007/s00253-011-3468-z
  • Kase, H., Iwahashi, K., Nakanishi, S., Matsuda, Y., Yamada, K., Takahashi, M., Murakata, C., … Kaneko, M. (1987). K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochemical and Biophysical Research Communications, 142, 436–440.10.1016/0006-291X(87)90293-2
  • Kodach, L. L., Bos, C. L., Durán, N., Peppelenbosch, M. P., Ferreira, C. V., & Hardwick, J. C. H. (2006). Violacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cells. Carcinogenesis, 27, 508–516.10.1093/carcin/bgi307
  • Matz, C., Deines, P., Boenigk, J., Arndt, H., Eberl, L., Kjelleberg, S., & Jürgens, K. (2004). Impact of violacein-producing bacteria on survival and feeding of bacterivorous nanoflagellates. Applied and Environmental Microbiology, 70, 1593–1599.10.1128/AEM.70.3.1593-1599.2004
  • Mellor, H., & Parker, P. J. (1998). The extended protein kinase C superfamily. Biochemical Journal, 332, 281–292.10.1042/bj3320281
  • Mizuno, K., Noda, K., Ueda, Y., Hanaki, H., Saido, T. C., Ikuta, T., … Ohno, S. (1995). UCN-01, an anti-tumor drug, is a selective inhibitor of the conventional PKC subfamily. FEBS Letters, 359, 259–261.10.1016/0014-5793(95)00042-8
  • Sánchez, C., Braña, A. F., Méndez, C., & Salas, J. A. (2006). Reevaluation of the violacein biosynthetic pathway and its relationship to indolocarbazole biosynthesis. ChemBioChem, 7, 1231–1240.10.1002/cbic.v7:8
  • Seynaeve, C. M., Kazaniets, M. G., Blumberg, P. M., Sausville, E. A., & Worland, P. J. (1994). Differential inhibition of protein kinase C isozymes by UCN-01, a staurosporine analogue. Molecular pharmacology, 45, 1207–1214.
  • Soliev, A. B., Hosokawa, K., & Enomoto, K. (2015). Effects of prodigiosin family compounds from Pseudoalteromonas sp. 1020R on the activities of protein phosphatases and protein kinases. Journal of Enzyme Inhibition and Medicinal Chemistry, 30, 533–538.10.3109/14756366.2014.951347
  • Stevenson, C. S., Capper, E. A., Roshak, A. K., Marquez, B., Grace, K., Gerwick, W. H., … Marshall, L. A. (2002). Scytonemin—A marine natural product inhibitor of kinases key in hyperproliferative inflammatory diseases. Inflammation Research, 51, 112–114.10.1007/BF02684014
  • Tamaoki, T., & Nakano, H. (1990). Potent and specific inhibitors of protein Kinase C of microbial origin. Nature Biotechnology, 8, 732–735.10.1038/nbt0890-732
  • Toomik, R., & Ek, P. (1997). A potent and highly selective peptide substrate for protein kinase C assay. Biochemical Journal, 322, 455–460.10.1042/bj3220455
  • Ward, N. E., & O’Brian, C. A. (1992). Kinetic analysis of protein kinase C inhibition by staurosporine: Evidence that inhibition entails inhibitor binding at a conserved region of the catalytic domain but not competition with substrates. Molecular pharmacology, 41, 387–392.
  • Yada, S., Wang, Y., Zou, Y., Nagasaki, K., Hosokawa, K., Osaka, I., … Enomoto, K. (2008). Isolation and characterization of two groups of novel marine bacteria producing violacein. Marine Biotechnology, 10, 128–132.10.1007/s10126-007-9046-9